Assignee
BIOPROJET PHARMA
FR·3 granted patents·5 pending applications·0 citations·filing 2018–2025
Top patents by PatentIndex Score
8 records- 0179US2026034114A1Enteric coated pitolisant formulations and methods of useBIOPROJET PHARMA·Filed 2025·Application pending·0 cites
- 0278US2025120959A1New formulations of pitolisant and methods of useBIOPROJET PHARMA·Filed 2024·Application pending·0 cites
- 0376US2025120918A1New formulations of pitolisant and methods of useBIOPROJET PHARMA·Filed 2024·Application pending·0 cites
- 0467US12145916B2Polymorph form of pitolisant hydrochlorideBIOPROJET PHARMA·Filed 2024·Granted Nov 19, 2024·0 cites·15 claims
- 0564US2025186353A1Enteric coated pitolisant formulations and methods of useBIOPROJET PHARMA·Filed 2025·Application pending·0 cites
- 0659US2025154117A1Polymorph form of pitolisant hydrochlorideBIOPROJET PHARMA·Filed 2024·Application pending·0 cites
- 0750US12582648B2Method for treating central nervous system disorders using dopamine D3 partial agonistsBIOPROJET PHARMA·Filed 2021·Granted Mar 24, 2026·0 cites·4 claims
- 0840US11179329B2Therapeutical use of H3-ligandsBIOPROJET PHARMA·Filed 2018·Granted Nov 23, 2021·0 cites·18 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →